Berkshire Hathaway Inc. (Class B) (BRK-B)
Verdict history · BRK-B
Every call Verdix has made on BRK-B.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call BRK-B yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials / Diversified Holding Company · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing frameworks dissect Berkshire Hathaway at $504, where a fortress balance sheet and aggressive buybacks meet a price that offers almost no margin of safety. The debate turns on whether Greg Abel can productively deploy $236 billion in idle cash, with the panel landing on a cautious WAIT: great business, wrong price.Level to watch
Key support 500.88−0.6% from 504.03
Next catalyst
Key support to watch: A pullback into the $483–$492 zone would land the stock at the volume point of control and the weekly 61.8% Fibonacci retracement, a historical accumulation zone where several archetypes would turn more constructive.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 504.03
The business-quality split is overwhelmingly bullish (The Moat Compounder, The Quality Rationalist, The Asymmetric Bargainer, The Forensic Skeptic all BUY, sentiment Bullish), but the cautious camp is dominated by PRICE/TIMING objections, not BUSINESS ones. Technical-scout and The Intrinsic-Value Modeler both want a better entry ($470–$492 zone) and fundamental scout explicitly says "new entries may want to wait for a better margin of safety." The Margin-of-Safety Hunter is the sole BUSINESS-objector and his objection is structural (no dividend, per his defensive framework), not thesis-breaking. This is a classic BUY vs WAIT split — great business, wrong price — which under Step B synthesizes to WAIT.
Key levels
Key levels · BRK-B
USD · as of 2026-08-15Analyst consensus target 504.03 USD · range 504.03–504.03
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Berkshire Hathaway Inc. (Class B) past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: Management repurchased $5–11 billion in a single quarter, the loudest signal that intrinsic value sits well above $504 per share and that the people who know this collection of businesses best are buying with both hands. Conviction: Conviction strengthens because the buyback signal, $110/share in net cash, and 1.4x book value (near the low end of the historical range) are three independent facts all pointing the same direction.
The Quality RationalistMental Models/Quality🟢 BullishMed
Signal: Berkshire's insurance float model generates a negative-cost source of capital that no competitor can replicate, and the buyback program effectively retires every dollar of intrinsic value at roughly 80 cents on the dollar, compounding per-share worth quietly over time. Conviction: Conviction is tempered by one unresolved question: whether Greg Abel can deploy the $236 billion cash pile at high returns across a full economic cycle, since the Taylor Morrison deal is only one data point.
The Margin-of-Safety HunterValue/Quantitative⚫ NeutralMed
Signal: The Margin-of-Safety Hunter Number calculates to approximately $549, leaving an 8.2% margin of safety that falls well short of the 25–33% discount a defensive purchase demands, and the absence of any dividend fails a foundational screen. Conviction: Confidence is held back because two criteria — the borderline price-to-book ratio and reliance on volatile investment gains for reported earnings — both hinge on assumptions that a single recession could overturn.
The Asymmetric BargainerContrarian/Deep Value🟢 BullishMed
Signal: Net cash of $110 per share puts a hard floor under the downside, meaning a severe recession might clip 20–25% at most while the upside case delivers 150–200% if Berkshire deploys its war chest during the next panic. Conviction: Conviction is high because four independent checks — simple business, limited downside, substantial upside, favorable odds — all pass, and management's own capital is aligned alongside shareholders through aggressive buybacks.
The Forensic SkepticContrarian/Forensic🟢 BullishMed
Signal: Strip out unrealized investment gains and normalized operating earnings put the real price-to-earnings multiple at roughly 12–14x, not the forward 23x the market sees, exposing a gap between reported noise and durable earning power. Conviction: Conviction gains traction because the buyback pace, cash optionality, and historically cheap 1.4x book value all reinforce the same conclusion, yet it stays at 68% because a slowdown in repurchases below $3 billion per quarter would invalidate the central signal.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: The base-case discounted cash flow puts intrinsic value at roughly $512, nearly identical to the current price, with a bear case at $445 if the cash pile stays idle and a bull case at $570 only if management deploys capital at double-digit returns on invested capital. Conviction: Conviction stays cautious because the entire bull case depends on one contested assumption: that Greg Abel can invest $100 billion-plus of idle cash at high rates of return, and there is not yet enough evidence to underwrite that with confidence.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six archetypes agree that Berkshire's balance sheet is fortress-grade, with net cash of roughly $110 per share and a debt-to-equity ratio of 0.17 providing rare downside protection.
- Five of six agree the underlying operating businesses (insurance, railroad, utilities, manufacturing) are durable and generate dependable cash flow; the lone structural objection is the Margin-of-Safety Hunter's dividend criterion, not a dispute about business quality.
- Every archetype recognizes the buyback program as a meaningful signal: management is putting capital behind the view that the stock is undervalued.
- No archetype sees an immediate SELL case; the split is between buying now and waiting for a better price.
The real debate
- The Moat Compounder and The Forensic Skeptic both see normalized operating earnings revealing a much cheaper real multiple, while The Intrinsic-Value Modeler counters that the forward P/E of 23x correctly anticipates investment-gain mean-reversion and leaves no bargain at $504.
- The Asymmetric Bargainer treats the $110/share cash position as a downside floor that tilts the balance of outcomes strongly positive, but The Margin-of-Safety Hunter treats that same cash as a drag on returns that does not compensate for an inadequate 8.2% discount to the Margin-of-Safety Hunter Number.
- The Quality Rationalist wants to see two to three more large deals under Greg Abel before pricing in full optionality value, while The Moat Compounder argues the Taylor Morrison acquisition and the buyback pace already demonstrate capable capital allocation.
The question it comes down to: Can Greg Abel deploy the $236 billion cash pile at high enough returns, and fast enough, to justify paying within 1% of estimated intrinsic value today — or is patience through the next pullback the smarter capital-allocation decision?
The bottom line
- Key support to watch: A pullback into the $483–$492 zone would land the stock at the volume point of control and the weekly 61.8% Fibonacci retracement, a historical accumulation zone where several archetypes would turn more constructive.
- Trigger to confirm momentum: A weekly close above $516.85 would signal re-acceleration and could shift the timing-oriented skeptics toward the buy side.
- Risk to monitor: If quarterly buybacks drop below $3 billion, the central bullish signal collapses and the bear case ($445) gains credibility.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in BRK-B · BRK-B verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated